Considering the economic impact of
Posted: Thu Feb 20, 2025 6:48 am
For companies, monitoring this legislative movement, understanding which topics have received the most attention and the general interest of public agents, ensures that products and services will be in compliance with the regulatory changes that are so frequent and common in Brazil. It is essential to monitor the regulatory impact for each market. Here, we highlight some data related to the pharmaceutical sector .
When we consider, for example, the terms “medicine” and “medication”, we see an increase in the number of bills of 400% for the first term, between 2018 and 2020, and of 40% for the second, totaling more than 300 bills presented this year alone in the sum of the two indexes.
Regarding proposals that deal with the subject of “vaccines”, as romania mobile database expected, in 2020 four times more projects were presented, when compared to 2018 and 2019 separately. Here, it is also important to note that there are still almost two months left until the end of the year and this topic (as we can see from the current agenda on Coronavac) remains intense.
When we analyze the speeches of parliamentarians, we also notice this trend. There were 113 speeches about vaccines in the National Congress in 2020. Last year, there were only 47, and in 2018, not even that: only 37.
We also analyzed the number of news items published on legislative portals and in a few media outlets such as G1 Política, Valor Política or Radar da Veja. Here the numbers are even more impressive. In the last 30 days alone, there were 739 news items about “vaccine”, 115 about “pharmaceuticals” and 1,135 about “medicine”.
If your organization's core business is regulated, it is impossible to do without this type of information. In this particular case, it is clear that for pharmaceutical companies, legislative monitoring, regulatory risk management, as well as detailed analysis of the measures presented in this context, can provide important information about possible fields of action, increased production or import of a product, logistical challenges on the horizon or possible pent-up demand.
The pandemic, the relevance of these issues in a context of health emergency is great, it can provoke significant changes in business and give a new tone to companies' strategies, either by enabling them to avoid threats or take advantage of opportunities.
When we consider, for example, the terms “medicine” and “medication”, we see an increase in the number of bills of 400% for the first term, between 2018 and 2020, and of 40% for the second, totaling more than 300 bills presented this year alone in the sum of the two indexes.
Regarding proposals that deal with the subject of “vaccines”, as romania mobile database expected, in 2020 four times more projects were presented, when compared to 2018 and 2019 separately. Here, it is also important to note that there are still almost two months left until the end of the year and this topic (as we can see from the current agenda on Coronavac) remains intense.
When we analyze the speeches of parliamentarians, we also notice this trend. There were 113 speeches about vaccines in the National Congress in 2020. Last year, there were only 47, and in 2018, not even that: only 37.
We also analyzed the number of news items published on legislative portals and in a few media outlets such as G1 Política, Valor Política or Radar da Veja. Here the numbers are even more impressive. In the last 30 days alone, there were 739 news items about “vaccine”, 115 about “pharmaceuticals” and 1,135 about “medicine”.
If your organization's core business is regulated, it is impossible to do without this type of information. In this particular case, it is clear that for pharmaceutical companies, legislative monitoring, regulatory risk management, as well as detailed analysis of the measures presented in this context, can provide important information about possible fields of action, increased production or import of a product, logistical challenges on the horizon or possible pent-up demand.
The pandemic, the relevance of these issues in a context of health emergency is great, it can provoke significant changes in business and give a new tone to companies' strategies, either by enabling them to avoid threats or take advantage of opportunities.